期刊文献+

肝细胞癌RUNX3基因甲基化与杂合缺失的分析及其意义 被引量:21

Analysis of methylation and loss of heterozygosity of RUNX3 gene in hepatocellular carcinoma and its clinical significance
原文传递
导出
摘要 目的 通过筛查肝细胞癌(HCC)RUNX3遗传学和表遗传学异常,拟明确RUNX3基因在HCC发病过程中的作用。方法 采用聚合酶链反应(PCR)单链构象多态性、杂合缺失(LOH)分析、测序以及DNA甲基化特异的PCR技术对90例HCC RUNX3基因突变、LOH及甲基化状态进行检测,对RUNX3基因缺失、甲基化结果与各临床病理参数的关系进行分析。结果 未发现突变病例;但发现3个单核苷酸多态性分别存在于外显子1和4;LOH分析表明30.6%(11/36)的病例存在LOH;54.4%(49/90)的病例存在RUNX3基因高甲基化;RUNX3 LOH与HCC门静脉癌栓、肝内转移和微血管受侵差异有显著性(x^2值分别为4.729、4.581、4.581,P值均<0.05)。结论 HCC RUNX3基因存在高频率的LOH和高甲基化;RUNX3基因的异常可能在HCC发病过程中起重要作用。 Objective In order to elucidate role of RUNX3 gene in hepatocarcinogenesis, we detected genetic and epigenetic alteration of RUNX3 gene in hepatocellular carcinoma (HCC). Methods PCR-SSCP, analysis of loss of heterozygosity (LOH), sequencing and methylation-specific PCR (MSP) were used to detect mutation, LOH and DNA methylation of RUNX3 gene in 90 HCCs. Result No mutation was found, but three single-nucleotide polymorphisms (SNP) were found and distributed over exonl and exon4. 30.6% (11/36) of cases showed LOH; 54.4% (49/90) of cases was in hypermethylation. There is a significant correlation between LOH and major portal vein invasive or micro vessel invasion or intrahepatic metastasis (P<0.05). Conclusion High frequent hypermthylation and LOH of RUNX3 gene were found in HCC. Aberrant RUNX3 gene may play an important role in the development of HCC.
出处 《中华肝脏病杂志》 CAS CSCD 2004年第4期227-230,共4页 Chinese Journal of Hepatology
关键词 肝细胞癌 RUNX3基因 基因杂合缺失 基因甲基化 遗传学 Carcinoma, hepatocellular Gene, RUNX3 DNA methylation Loss of heterozygosity
  • 相关文献

参考文献9

  • 1Laurent Puig P, Legoix P, Bluteau O, et al. Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepoatocarcinogenesis. Gastroenterology, 2001, 120: 1763-1773.
  • 2Bergsland EK. Molecular mechanisms underlying the development of hepatocellular carcinoma. Semin Oncol, 2001, 28: 521-531.
  • 3Li QL, Ito K, Sakaura C, et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell, 2002, 109:113-124.
  • 4Fang W, Piao Z, Simon D, et al. Mapping of a minimal deleted region in human hepatocellular carcinoma to l p36.13-p36.33 and mutational analysis of the RIZ (PRDM2) gene localized to the region.Genes Chromosomes Cancer, 2000, 28: 269-275.
  • 5Zaidi SK, Sullivon AJ, Wijnen AJV, et al. Integration of Runx and Smad regulatory signals at transcriptionally active subnuclear sites.Proc Natl Acad Sci, 2002, 99: 8048-8053.
  • 6Song BC, Chung YH, Kim JA, et al. Transforming growth factorbetal as a useful serologic marker of small hepatocellular carcinoma.Cancer, 2002, 94: 175-180.
  • 7Matuzaki K, Date M, Furukawa F, et al. Regulatory mechanisms for transforming growth factor beta as an autocrine inhibitor in human hepatocellalar carcinoma: implications for roles of smads in its growth.Hepatology, 2000, 32: 218-227.
  • 8肖文华,刘为纹,吕有勇,高崇峰.肝细胞癌多种抑癌基因失活机理的研究[J].第三军医大学学报,1997,19(4):324-328. 被引量:10
  • 9肖文华,刘为纹,吕有勇,高崇峰.Rb基因在肝细胞癌中的多种失活机制[J].中华肝脏病杂志,1997,5(3):142-144. 被引量:4

二级参考文献2

  • 1Zhang X,Cancer Res,1994年,54卷,4177页
  • 2Huang Y,Cancer Res,1992年,52卷,6525页

共引文献12

同被引文献192

引证文献21

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部